Orofacial dyskinesia

Orofacial Dyskinesia is a type of dyskinesia specifically affecting the mouth, jaw, and face. This condition is characterized by involuntary, repetitive movements that can include grimacing, tongue protrusion, lip smacking, puckering, and rapid eye blinking. Orofacial dyskinesia is often associated with long-term use of certain psychotropic medication, particularly antipsychotics, and is a form of tardive dyskinesia. It can significantly impact a person's quality of life, affecting their ability to speak, eat, and maintain social interactions.

Causes

The primary cause of orofacial dyskinesia is prolonged exposure to neuroleptic or antipsychotic medications, which are used to treat psychiatric conditions such as schizophrenia and bipolar disorder. These medications can lead to the depletion of dopamine in the brain, which is thought to be a contributing factor to the development of the condition. Other potential causes include the use of other drugs that affect the brain's dopamine system, such as metoclopramide (a medication used to treat nausea and gastrointestinal issues), and conditions that cause damage to the basal ganglia, a part of the brain involved in movement control.

Symptoms

Symptoms of orofacial dyskinesia include:

• Involuntary movements of the mouth, jaw, and tongue
• Grimacing
• Lip smacking and puckering
• Tongue protrusion
• Rapid eye blinking
• Difficulty in speaking and eating

These symptoms can be distressing and may lead to social withdrawal and emotional distress.

Diagnosis

Diagnosis of orofacial dyskinesia involves a thorough medical history and physical examination. Healthcare providers will look for the characteristic symptoms and inquire about the use of medications that could contribute to the condition. There are no specific tests for orofacial dyskinesia, but tests may be conducted to rule out other conditions that could cause similar symptoms.

Treatment

Treatment of orofacial dyskinesia focuses on managing symptoms and may include:

• Reducing or discontinuing the use of causative medications, under medical supervision
• Use of medications such as tetrabenazine, which can help reduce involuntary movements
• Physical therapy to help manage symptoms
• Speech therapy to address difficulties with speaking and eating

In some cases, switching to a different class of antipsychotic medication may be recommended.

Prevention

Preventing orofacial dyskinesia involves careful use of antipsychotic medications, including monitoring for early signs of movement disorders and considering alternative treatments when appropriate. Regular follow-up with healthcare providers is essential for individuals taking these medications.

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian